 | • レポートコード：QYR2104Z5620 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、治療薬モニタリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学発光イムノアッセイ（CLIA）、蛍光イムノアッセイ（FPIA）、ラジオイムノアッセイ（RIA）、比色イムノアッセイ、その他イムノアッセイ）、用途別市場規模（抗てんかん薬、免疫抑制薬、抗腫瘍薬、向精神薬、抗生物質、抗真菌薬、心血管治療薬、抗喘息薬、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・治療薬モニタリングの市場動向 ・企業の競争状況、市場シェア ・治療薬モニタリングの種類別市場規模（化学発光イムノアッセイ（CLIA）、蛍光イムノアッセイ（FPIA）、ラジオイムノアッセイ（RIA）、比色イムノアッセイ、その他イムノアッセイ） ・治療薬モニタリングの用途別市場規模（抗てんかん薬、免疫抑制薬、抗腫瘍薬、向精神薬、抗生物質、抗真菌薬、心血管治療薬、抗喘息薬、その他） ・治療薬モニタリングの北米市場規模2016-2027（アメリカ、カナダ） ・治療薬モニタリングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・治療薬モニタリングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・治療薬モニタリングの中南米市場規模2016-2027（メキシコ、ブラジル） ・治療薬モニタリングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche AG、Siemens Healthineers、Thermo Fisher Scientific、Beckman Coulter、Agilent Technologies、BioMérieux、Sekisui Medical、DiaSorin、Fujirebio、Grifols、Ortho-Clinical Diagnostics、Quest Diagnostics、Sysmex、Tosoh、Chromsystems、Bio-Rad、R-Biopharm AG、ALPCO、BIOHIT Healthcare、MedTox、Wieslab、ARK Diagnostics、Probe Scientific、Omnica） ・結論 |
Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the blood. Monitored drugs tend to have a narrow “therapeutic index,” – the difference between the toxic and therapeutic doses of medications. For some drugs, maintaining this steady concentration in the blood is not as simple as giving a standard dose of medication to everyone. Each person will absorb, metabolise, utilise, and eliminate drugs at different rates based upon their age, general state of health, genetic makeup, and the influence of other medications that they are taking. These factors may change over time and vary from day to day or with various disease states.
Market Analysis and Insights: Global Theraputic Drug Monitorings Market
The global Theraputic Drug Monitorings market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Theraputic Drug Monitorings market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Theraputic Drug Monitorings market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Theraputic Drug Monitorings market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Theraputic Drug Monitorings market.
Global Theraputic Drug Monitorings Scope and Market Size
Theraputic Drug Monitorings market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Theraputic Drug Monitorings market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FPIA)
Radioimmunoassay (RIA)
Colorimetric Immunoassay
Other Immunoassays
Segment by Application
Antiepileptic Drugs
Immunosuppressant
Antitumor Drugs
Psychotropic Drugs
Antibiotic
Antifungal
Cardiovascular Drugs
Antiasthmatic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche AG
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
BioMérieux
Sekisui Medical
DiaSorin
Fujirebio
Beckman Coulter
Agilent Technologies
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio-Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Theraputic Drug Monitorings Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemiluminescence Immunoassay (CLIA)
1.2.3 Fluorescence Immunoassay (FPIA)
1.2.4 Radioimmunoassay (RIA)
1.2.5 Colorimetric Immunoassay
1.2.6 Other Immunoassays
1.3 Market by Application
1.3.1 Global Theraputic Drug Monitorings Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Antiepileptic Drugs
1.3.3 Immunosuppressant
1.3.4 Antitumor Drugs
1.3.5 Psychotropic Drugs
1.3.6 Antibiotic
1.3.7 Antifungal
1.3.8 Cardiovascular Drugs
1.3.9 Antiasthmatic
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Theraputic Drug Monitorings Market Perspective (2016-2027)
2.2 Theraputic Drug Monitorings Growth Trends by Regions
2.2.1 Theraputic Drug Monitorings Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Theraputic Drug Monitorings Historic Market Share by Regions (2016-2021)
2.2.3 Theraputic Drug Monitorings Forecasted Market Size by Regions (2022-2027)
2.3 Theraputic Drug Monitorings Industry Dynamic
2.3.1 Theraputic Drug Monitorings Market Trends
2.3.2 Theraputic Drug Monitorings Market Drivers
2.3.3 Theraputic Drug Monitorings Market Challenges
2.3.4 Theraputic Drug Monitorings Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Theraputic Drug Monitorings Players by Revenue
3.1.1 Global Top Theraputic Drug Monitorings Players by Revenue (2016-2021)
3.1.2 Global Theraputic Drug Monitorings Revenue Market Share by Players (2016-2021)
3.2 Global Theraputic Drug Monitorings Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Theraputic Drug Monitorings Revenue
3.4 Global Theraputic Drug Monitorings Market Concentration Ratio
3.4.1 Global Theraputic Drug Monitorings Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Theraputic Drug Monitorings Revenue in 2020
3.5 Theraputic Drug Monitorings Key Players Head office and Area Served
3.6 Key Players Theraputic Drug Monitorings Product Solution and Service
3.7 Date of Enter into Theraputic Drug Monitorings Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Theraputic Drug Monitorings Breakdown Data by Type
4.1 Global Theraputic Drug Monitorings Historic Market Size by Type (2016-2021)
4.2 Global Theraputic Drug Monitorings Forecasted Market Size by Type (2022-2027)
5 Theraputic Drug Monitorings Breakdown Data by Application
5.1 Global Theraputic Drug Monitorings Historic Market Size by Application (2016-2021)
5.2 Global Theraputic Drug Monitorings Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Theraputic Drug Monitorings Market Size (2016-2027)
6.2 North America Theraputic Drug Monitorings Market Size by Type
6.2.1 North America Theraputic Drug Monitorings Market Size by Type (2016-2021)
6.2.2 North America Theraputic Drug Monitorings Market Size by Type (2022-2027)
6.2.3 North America Theraputic Drug Monitorings Market Size by Type (2016-2027)
6.3 North America Theraputic Drug Monitorings Market Size by Application
6.3.1 North America Theraputic Drug Monitorings Market Size by Application (2016-2021)
6.3.2 North America Theraputic Drug Monitorings Market Size by Application (2022-2027)
6.3.3 North America Theraputic Drug Monitorings Market Size by Application (2016-2027)
6.4 North America Theraputic Drug Monitorings Market Size by Country
6.4.1 North America Theraputic Drug Monitorings Market Size by Country (2016-2021)
6.4.2 North America Theraputic Drug Monitorings Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Theraputic Drug Monitorings Market Size (2016-2027)
7.2 Europe Theraputic Drug Monitorings Market Size by Type
7.2.1 Europe Theraputic Drug Monitorings Market Size by Type (2016-2021)
7.2.2 Europe Theraputic Drug Monitorings Market Size by Type (2022-2027)
7.2.3 Europe Theraputic Drug Monitorings Market Size by Type (2016-2027)
7.3 Europe Theraputic Drug Monitorings Market Size by Application
7.3.1 Europe Theraputic Drug Monitorings Market Size by Application (2016-2021)
7.3.2 Europe Theraputic Drug Monitorings Market Size by Application (2022-2027)
7.3.3 Europe Theraputic Drug Monitorings Market Size by Application (2016-2027)
7.4 Europe Theraputic Drug Monitorings Market Size by Country
7.4.1 Europe Theraputic Drug Monitorings Market Size by Country (2016-2021)
7.4.2 Europe Theraputic Drug Monitorings Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Theraputic Drug Monitorings Market Size (2016-2027)
8.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Type
8.2.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2027)
8.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Application
8.3.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2027)
8.4 Asia-Pacific Theraputic Drug Monitorings Market Size by Region
8.4.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Theraputic Drug Monitorings Market Size (2016-2027)
9.2 Latin America Theraputic Drug Monitorings Market Size by Type
9.2.1 Latin America Theraputic Drug Monitorings Market Size by Type (2016-2021)
9.2.2 Latin America Theraputic Drug Monitorings Market Size by Type (2022-2027)
9.2.3 Latin America Theraputic Drug Monitorings Market Size by Type (2016-2027)
9.3 Latin America Theraputic Drug Monitorings Market Size by Application
9.3.1 Latin America Theraputic Drug Monitorings Market Size by Application (2016-2021)
9.3.2 Latin America Theraputic Drug Monitorings Market Size by Application (2022-2027)
9.3.3 Latin America Theraputic Drug Monitorings Market Size by Application (2016-2027)
9.4 Latin America Theraputic Drug Monitorings Market Size by Country
9.4.1 Latin America Theraputic Drug Monitorings Market Size by Country (2016-2021)
9.4.2 Latin America Theraputic Drug Monitorings Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Theraputic Drug Monitorings Market Size (2016-2027)
10.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Type
10.2.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2027)
10.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Application
10.3.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2027)
10.4 Middle East & Africa Theraputic Drug Monitorings Market Size by Country
10.4.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche AG
11.1.1 Roche AG Company Details
11.1.2 Roche AG Business Overview
11.1.3 Roche AG Theraputic Drug Monitorings Introduction
11.1.4 Roche AG Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.1.5 Roche AG Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Details
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Theraputic Drug Monitorings Introduction
11.2.4 Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.2.5 Siemens Healthineers Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Theraputic Drug Monitorings Introduction
11.3.4 Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Theraputic Drug Monitorings Introduction
11.4.4 Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.4.5 Beckman Coulter Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Theraputic Drug Monitorings Introduction
11.5.4 Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.5.5 Agilent Technologies Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Details
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux Theraputic Drug Monitorings Introduction
11.6.4 BioMérieux Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.6.5 BioMérieux Recent Development
11.7 Sekisui Medical
11.7.1 Sekisui Medical Company Details
11.7.2 Sekisui Medical Business Overview
11.7.3 Sekisui Medical Theraputic Drug Monitorings Introduction
11.7.4 Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.7.5 Sekisui Medical Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Theraputic Drug Monitorings Introduction
11.8.4 DiaSorin Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.8.5 DiaSorin Recent Development
11.9 Fujirebio
11.9.1 Fujirebio Company Details
11.9.2 Fujirebio Business Overview
11.9.3 Fujirebio Theraputic Drug Monitorings Introduction
11.9.4 Fujirebio Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.9.5 Fujirebio Recent Development
11.10 Grifols
11.10.1 Grifols Company Details
11.10.2 Grifols Business Overview
11.10.3 Grifols Theraputic Drug Monitorings Introduction
11.10.4 Grifols Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.10.5 Grifols Recent Development
11.11 Ortho-Clinical Diagnostics
11.11.1 Ortho-Clinical Diagnostics Company Details
11.11.2 Ortho-Clinical Diagnostics Business Overview
11.11.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Introduction
11.11.4 Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.11.5 Ortho-Clinical Diagnostics Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Details
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Theraputic Drug Monitorings Introduction
11.12.4 Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.12.5 Quest Diagnostics Recent Development
11.13 Sysmex
11.13.1 Sysmex Company Details
11.13.2 Sysmex Business Overview
11.13.3 Sysmex Theraputic Drug Monitorings Introduction
11.13.4 Sysmex Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.13.5 Sysmex Recent Development
11.14 Tosoh
11.14.1 Tosoh Company Details
11.14.2 Tosoh Business Overview
11.14.3 Tosoh Theraputic Drug Monitorings Introduction
11.14.4 Tosoh Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.14.5 Tosoh Recent Development
11.15 Chromsystems
11.15.1 Chromsystems Company Details
11.15.2 Chromsystems Business Overview
11.15.3 Chromsystems Theraputic Drug Monitorings Introduction
11.15.4 Chromsystems Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.15.5 Chromsystems Recent Development
11.16 Bio-Rad
11.16.1 Bio-Rad Company Details
11.16.2 Bio-Rad Business Overview
11.16.3 Bio-Rad Theraputic Drug Monitorings Introduction
11.16.4 Bio-Rad Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.16.5 Bio-Rad Recent Development
11.17 R-Biopharm AG
11.17.1 R-Biopharm AG Company Details
11.17.2 R-Biopharm AG Business Overview
11.17.3 R-Biopharm AG Theraputic Drug Monitorings Introduction
11.17.4 R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.17.5 R-Biopharm AG Recent Development
11.18 ALPCO
11.18.1 ALPCO Company Details
11.18.2 ALPCO Business Overview
11.18.3 ALPCO Theraputic Drug Monitorings Introduction
11.18.4 ALPCO Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.18.5 ALPCO Recent Development
11.18 BIOHIT Healthcare
.1 BIOHIT Healthcare Company Details
.2 BIOHIT Healthcare Business Overview
.3 BIOHIT Healthcare Theraputic Drug Monitorings Introduction
.4 BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2016-2021)
.5 BIOHIT Healthcare Recent Development
11.20 MedTox
11.20.1 MedTox Company Details
11.20.2 MedTox Business Overview
11.20.3 MedTox Theraputic Drug Monitorings Introduction
11.20.4 MedTox Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.20.5 MedTox Recent Development
11.21 Wieslab
11.21.1 Wieslab Company Details
11.21.2 Wieslab Business Overview
11.21.3 Wieslab Theraputic Drug Monitorings Introduction
11.21.4 Wieslab Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.21.5 Wieslab Recent Development
11.22 ARK Diagnostics
11.22.1 ARK Diagnostics Company Details
11.22.2 ARK Diagnostics Business Overview
11.22.3 ARK Diagnostics Theraputic Drug Monitorings Introduction
11.22.4 ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.22.5 ARK Diagnostics Recent Development
11.23 Probe Scientific
11.23.1 Probe Scientific Company Details
11.23.2 Probe Scientific Business Overview
11.23.3 Probe Scientific Theraputic Drug Monitorings Introduction
11.23.4 Probe Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.23.5 Probe Scientific Recent Development
11.24 Omnica
11.24.1 Omnica Company Details
11.24.2 Omnica Business Overview
11.24.3 Omnica Theraputic Drug Monitorings Introduction
11.24.4 Omnica Revenue in Theraputic Drug Monitorings Business (2016-2021)
11.24.5 Omnica Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Theraputic Drug Monitorings Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemiluminescence Immunoassay (CLIA)
Table 3. Key Players of Fluorescence Immunoassay (FPIA)
Table 4. Key Players of Radioimmunoassay (RIA)
Table 5. Key Players of Colorimetric Immunoassay
Table 6. Key Players of Other Immunoassays
Table 7. Global Theraputic Drug Monitorings Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Theraputic Drug Monitorings Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Theraputic Drug Monitorings Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Theraputic Drug Monitorings Market Share by Regions (2016-2021)
Table 11. Global Theraputic Drug Monitorings Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Theraputic Drug Monitorings Market Share by Regions (2022-2027)
Table 13. Theraputic Drug Monitorings Market Trends
Table 14. Theraputic Drug Monitorings Market Drivers
Table 15. Theraputic Drug Monitorings Market Challenges
Table 16. Theraputic Drug Monitorings Market Restraints
Table 17. Global Theraputic Drug Monitorings Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Theraputic Drug Monitorings Market Share by Players (2016-2021)
Table 19. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2020)
Table 20. Ranking of Global Top Theraputic Drug Monitorings Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Theraputic Drug Monitorings Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Theraputic Drug Monitorings Product Solution and Service
Table 24. Date of Enter into Theraputic Drug Monitorings Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Theraputic Drug Monitorings Revenue Market Share by Type (2016-2021)
Table 28. Global Theraputic Drug Monitorings Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Theraputic Drug Monitorings Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Theraputic Drug Monitorings Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Theraputic Drug Monitorings Revenue Market Share by Application (2016-2021)
Table 32. Global Theraputic Drug Monitorings Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Theraputic Drug Monitorings Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche AG Company Details
Table 65. Roche AG Business Overview
Table 66. Roche AG Theraputic Drug Monitorings Product
Table 67. Roche AG Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 68. Roche AG Recent Development
Table 69. Siemens Healthineers Company Details
Table 70. Siemens Healthineers Business Overview
Table 71. Siemens Healthineers Theraputic Drug Monitorings Product
Table 72. Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 73. Siemens Healthineers Recent Development
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Theraputic Drug Monitorings Product
Table 77. Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. Beckman Coulter Company Details
Table 80. Beckman Coulter Business Overview
Table 81. Beckman Coulter Theraputic Drug Monitorings Product
Table 82. Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 83. Beckman Coulter Recent Development
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Theraputic Drug Monitorings Product
Table 87. Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. BioMérieux Company Details
Table 90. BioMérieux Business Overview
Table 91. BioMérieux Theraputic Drug Monitorings Product
Table 92. BioMérieux Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 93. BioMérieux Recent Development
Table 94. Sekisui Medical Company Details
Table 95. Sekisui Medical Business Overview
Table 96. Sekisui Medical Theraputic Drug Monitorings Product
Table 97. Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 98. Sekisui Medical Recent Development
Table 99. DiaSorin Company Details
Table 100. DiaSorin Business Overview
Table 101. DiaSorin Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 102. DiaSorin Recent Development
Table 103. Fujirebio Company Details
Table 104. Fujirebio Business Overview
Table 105. Fujirebio Theraputic Drug Monitorings Product
Table 106. Fujirebio Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 107. Fujirebio Recent Development
Table 108. Grifols Company Details
Table 109. Grifols Business Overview
Table 110. Grifols Theraputic Drug Monitorings Product
Table 111. Grifols Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 112. Grifols Recent Development
Table 113. Ortho-Clinical Diagnostics Company Details
Table 114. Ortho-Clinical Diagnostics Business Overview
Table 115. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Product
Table 116. Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 117. Ortho-Clinical Diagnostics Recent Development
Table 118. Quest Diagnostics Company Details
Table 119. Quest Diagnostics Business Overview
Table 120. Quest Diagnostics Theraputic Drug Monitorings Product
Table 121. Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 122. Quest Diagnostics Recent Development
Table 123. Sysmex Company Details
Table 124. Sysmex Business Overview
Table 125. Sysmex Theraputic Drug Monitorings Product
Table 126. Sysmex Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 127. Sysmex Recent Development
Table 128. Tosoh Company Details
Table 129. Tosoh Business Overview
Table 130. Tosoh Theraputic Drug Monitorings Product
Table 131. Tosoh Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 132. Tosoh Recent Development
Table 133. Chromsystems Company Details
Table 134. Chromsystems Business Overview
Table 135. Chromsystems Theraputic Drug Monitorings Product
Table 136. Chromsystems Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 137. Chromsystems Recent Development
Table 138. Bio-Rad Company Details
Table 139. Bio-Rad Business Overview
Table 140. Bio-Rad Theraputic Drug Monitorings Product
Table 141. Bio-Rad Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 142. Bio-Rad Recent Development
Table 143. R-Biopharm AG Company Details
Table 144. R-Biopharm AG Business Overview
Table 145. R-Biopharm AG Theraputic Drug Monitorings Product
Table 146. R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 147. R-Biopharm AG Recent Development
Table 148. ALPCO Company Details
Table 149. ALPCO Business Overview
Table 150. ALPCO Theraputic Drug Monitorings Product
Table 151. ALPCO Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 152. ALPCO Recent Development
Table 153. BIOHIT Healthcare Company Details
Table 154. BIOHIT Healthcare Business Overview
Table 155. BIOHIT Healthcare Theraputic Drug Monitorings Product
Table 156. BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 157. BIOHIT Healthcare Recent Development
Table 158. MedTox Company Details
Table 159. MedTox Business Overview
Table 160. MedTox Theraputic Drug Monitorings Product
Table 161. MedTox Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 162. MedTox Recent Development
Table 163. Wieslab Company Details
Table 164. Wieslab Business Overview
Table 165. Wieslab Theraputic Drug Monitorings Product
Table 166. Wieslab Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 167. Wieslab Recent Development
Table 168. ARK Diagnostics Company Details
Table 169. ARK Diagnostics Business Overview
Table 170. ARK Diagnostics Theraputic Drug Monitorings Product
Table 171. ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 172. ARK Diagnostics Recent Development
Table 173. Probe Scientific Company Details
Table 174. Probe Scientific Business Overview
Table 175. Probe Scientific Theraputic Drug Monitorings Product
Table 176. Probe Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 177. Probe Scientific Recent Development
Table 178. Omnica Company Details
Table 179. Omnica Business Overview
Table 180. Omnica Theraputic Drug MonitoringsProduct
Table 181. Omnica Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
Table 182. Omnica Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Theraputic Drug Monitorings Market Share by Type: 2020 VS 2027
Figure 2. Chemiluminescence Immunoassay (CLIA) Features
Figure 3. Fluorescence Immunoassay (FPIA) Features
Figure 4. Radioimmunoassay (RIA) Features
Figure 5. Colorimetric Immunoassay Features
Figure 6. Other Immunoassays Features
Figure 7. Global Theraputic Drug Monitorings Market Share by Application: 2020 VS 2027
Figure 8. Antiepileptic Drugs Case Studies
Figure 9. Immunosuppressant Case Studies
Figure 10. Antitumor Drugs Case Studies
Figure 11. Psychotropic Drugs Case Studies
Figure 12. Antibiotic Case Studies
Figure 13. Antifungal Case Studies
Figure 14. Cardiovascular Drugs Case Studies
Figure 15. Antiasthmatic Case Studies
Figure 16. Others Case Studies
Figure 17. Theraputic Drug Monitorings Report Years Considered
Figure 18. Global Theraputic Drug Monitorings Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Theraputic Drug Monitorings Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Theraputic Drug Monitorings Market Share by Regions: 2020 VS 2027
Figure 21. Global Theraputic Drug Monitorings Market Share by Regions (2022-2027)
Figure 22. Global Theraputic Drug Monitorings Market Share by Players in 2020
Figure 23. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Theraputic Drug Monitorings Revenue in 2020
Figure 25. Global Theraputic Drug Monitorings Revenue Market Share by Type (2016-2021)
Figure 26. Global Theraputic Drug Monitorings Revenue Market Share by Type (2022-2027)
Figure 27. North America Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Theraputic Drug Monitorings Market Share by Type (2016-2027)
Figure 29. North America Theraputic Drug Monitorings Market Share by Application (2016-2027)
Figure 30. North America Theraputic Drug Monitorings Market Share by Country (2016-2027)
Figure 31. United States Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Theraputic Drug Monitorings Market Share by Type (2016-2027)
Figure 35. Europe Theraputic Drug Monitorings Market Share by Application (2016-2027)
Figure 36. Europe Theraputic Drug Monitorings Market Share by Country (2016-2027)
Figure 37. Germany Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Theraputic Drug Monitorings Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Theraputic Drug Monitorings Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Theraputic Drug Monitorings Market Share by Region (2016-2027)
Figure 47. China Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Theraputic Drug Monitorings Market Share by Type (2016-2027)
Figure 55. Latin America Theraputic Drug Monitorings Market Share by Application (2016-2027)
Figure 56. Latin America Theraputic Drug Monitorings Market Share by Country (2016-2027)
Figure 57. Mexico Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Theraputic Drug Monitorings Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Theraputic Drug Monitorings Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Theraputic Drug Monitorings Market Share by Country (2016-2027)
Figure 63. Turkey Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Roche AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 67. Siemens Healthineers Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 69. Beckman Coulter Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 70. Agilent Technologies Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 71. BioMérieux Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 72. Sekisui Medical Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 73. DiaSorin Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 74. Fujirebio Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 75. Grifols Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 76. Ortho-Clinical Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 77. Quest Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 78. Sysmex Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 79. Tosoh Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 80. Chromsystems Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 81. Bio-Rad Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 82. R-Biopharm AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 83. ALPCO Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 84. BIOHIT Healthcare Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 85. MedTox Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 86. Wieslab Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 87. ARK Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 88. Probe Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 89. Omnica Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
世界の治療薬モニタリング市場規模・現状・予測（2021年-2027年） Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the blood. Monitored drugs tend to have a narrow "therapeutic index," – the difference between the toxic and therapeutic doses of medicati…- 世界の蛍光イムノアッセイアナライザー市場 2021：企業別、地域別、種類・用途別 The Fluorescence Immunoassay Analyzers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 化学発光イムノアッセイ分析装置の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Chemiluminescence Immunoassay Analyzer from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is prese…
- 世界の定量的イムノアッセイ市場規模・現状・予測（2021年-2027年） Immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes). Market Analysis and Insights: Global Quantitative Immunoassay Market The global Quantitative Immunoas…
- 世界のイムノアッセイ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immunoassays Market The global Immunoassays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant…